Clinical Trial Update: A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the pharmacokinetics and pharmacodynamics of JNJ-54452840 in heart failure patients with anti-beta1-adrenergic receptor autoantibodie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• JNJ-54452840

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Heart Failure | Phase 2 | Status: WITHDRAWN